LDHA and neoplasm: Chen et  al reported that miR‐383 might inhibit HCC cell proliferation partially via down‐regulating APRIL (encoding a proliferation‐inducing ligand) expression.15 Fang et  al showed that miR‐383 is down‐regulated in HCC and acts as a tumour suppressor by targeting LDHA (encoding lactate dehydrogenase A).16 However, the role of miR‐383 in HCC chemoresistance remains unclear.